Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don L Gibbons

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
Journal of Virology|January 5, 2002
Molecular dissection of the Semliki Forest virus homotrimer reveals two functionally distinct regions of the fusion proteinDon L Gibbons, Margaret Kielian
Developmental Dynamics : an Official Publication of the American Association of Anatomists|January 11, 2017
Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome AtlasDon L Gibbons, Chad J Creighton
Cancers|April 23, 2022
Regulation of ZEB1 Function and Molecular Associations in Tumor Progression and MetastasisMabel Perez-Oquendo, Don L Gibbons
Cell Reports. Medicine|February 2, 2022
MEK inhibition invigorates chemoimmunotherapy by tumor mitophagy-induced CXCL10 expressionB Leticia Rodriguez, Don L Gibbons
Cancer Discovery|September 4, 2014
A HER 1-2 punch: dual EGFR targeting deals resistance a deadly blowDon L Gibbons, Lauren Averett Byers
Journal of Virology|March 9, 2002
The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domainsAnna Ahn, Don L Gibbons, Margaret Kielian
Trends in Pharmacological Sciences|May 14, 2024
Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunitiesJessica M Konen, Haoyi Wu, Don L Gibbons
Cancers|July 27, 2024
The Multifaceted Role of Neutrophils in NSCLC in the Era of Immune Checkpoint InhibitorsShucheng Miao, Bertha Leticia Rodriguez, Don L Gibbons
Cells|December 28, 2019
The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid TumorsJessica M Konen, Jared J Fradette, Don L Gibbons
Cancer Management and Research|August 30, 2013
The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspectiveChad J Creighton, Don L Gibbons, Jonathan M Kurie
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Journal of Virology|January 5, 2002
Molecular dissection of the Semliki Forest virus homotrimer reveals two functionally distinct regions of the fusion proteinDon L Gibbons, Margaret Kielian
Developmental Dynamics : an Official Publication of the American Association of Anatomists|January 11, 2017
Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome AtlasDon L Gibbons, Chad J Creighton
Cancers|April 23, 2022
Regulation of ZEB1 Function and Molecular Associations in Tumor Progression and MetastasisMabel Perez-Oquendo, Don L Gibbons
Cell Reports. Medicine|February 2, 2022
MEK inhibition invigorates chemoimmunotherapy by tumor mitophagy-induced CXCL10 expressionB Leticia Rodriguez, Don L Gibbons
Cancer Discovery|September 4, 2014
A HER 1-2 punch: dual EGFR targeting deals resistance a deadly blowDon L Gibbons, Lauren Averett Byers
Journal of Virology|March 9, 2002
The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domainsAnna Ahn, Don L Gibbons, Margaret Kielian
Trends in Pharmacological Sciences|May 14, 2024
Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunitiesJessica M Konen, Haoyi Wu, Don L Gibbons
Cancers|July 27, 2024
The Multifaceted Role of Neutrophils in NSCLC in the Era of Immune Checkpoint InhibitorsShucheng Miao, Bertha Leticia Rodriguez, Don L Gibbons
Cells|December 28, 2019
The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid TumorsJessica M Konen, Jared J Fradette, Don L Gibbons
Cancer Management and Research|August 30, 2013
The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspectiveChad J Creighton, Don L Gibbons, Jonathan M Kurie
Pageof 20